Brunel University London is offering a fully funded PhD opportunity in the field of pharmaceutical engineering, focusing on advancing cardiovascular health through point-of-care 3D printing of personalised polypills. This innovative project aims to develop advanced pharmaceutical-related biomaterials and formulation strategies, leveraging additive manufacturing and 3D printing technologies to create personalised drug delivery systems. The research is highly multidisciplinary, integrating expertise from engineering, pharmaceutics, and medical sciences.

As a PhD student, you will gain hands-on experience in biomaterials development, pharmaceutical sciences, drug delivery, and healthcare policy. The project provides a unique opportunity to work within a collaborative supervisory team and to contribute to pioneering research in the development of functional engineered tissues and personalised medicine. The research group, led by Dr Bin Zhang, focuses on biofabrication techniques, organ-on-a-chip engineering, and the integration of 3D printing with drug-loading approaches for tissue regeneration and disease modelling.

The position is fully funded, covering tuition fees and providing a stipend for living expenses. Applicants should have a strong background in engineering, pharmaceutical sciences, biomaterials, or related disciplines, with experience in additive manufacturing or drug delivery considered advantageous. The application deadline is noon on Tuesday, 24 March 2026. For more information and to apply, visit the provided application link or contact Dr Bin Zhang directly for informal discussions.

Keywords: pharmaceutical engineering, additive manufacturing, 3D printing, biomaterials, drug delivery, personalised medicine, cardiovascular health, polypills, mechanical engineering, bioengineering.